USPTO Deadlines
Next Deadline
721 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-07-31)
Due Date
July 31, 2027
Grace Period Ends
January 31, 2028
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 2, 2018 | CAEX | O | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | Loading... |
| Jul 31, 2016 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Jan 14, 2013 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jan 14, 2013 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Jan 14, 2013 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Dec 18, 2012 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 18, 2012 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Jul 31, 2007 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 15, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 11, 2007 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 25, 2007 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 16, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 16, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 21, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 21, 2007 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 20, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 20, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 13, 2007 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 13, 2007 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 8, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 23, 2006 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
| Sep 22, 2006 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"TRADING CORP."